Macrophage/Monocyte Driven Inflammation and Anesthetic Sensitivity in Aging

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Chile

About this trial

The goal of this observational study is to determine whether macrophage/monocyte mediated inflammatory signaling contributes to reduced anesthetic requirements in older adults undergoing major abdominal surgery. The main questions it aims to answer are:

* Is there a difference in anesthetic dosing requirements (minimum effective dose) between young and older patients undergoing major abdominal surgery? * How do electroencephalographic (EEG) signatures under anesthesia correlate with age and systemic inflammatory markers? * Is there an association between age, levels of circulating inflammatory cytokines, and monocyte/macrophage phenotypes with anesthetic requirements?

If there is a comparison group: Researchers will compare older adult patients undergoing major abdominal surgery to younger adult patients undergoing major abdominal surgery to see if macrophage/monocyte-mediated inflammatory signaling influences anesthetic sensitivity and the risk of postoperative neurocognitive complications in the older population.

Participants will:

* Receive general anesthesia for major abdominal surgery, with continuous recording of anesthetic dose requirements. * Undergo electroencephalographic (EEG) monitoring during the anesthetic period. * Provide blood samples for the measurement of circulating inflammatory cytokines and the assessment of monocyte phenotypes. * Provide peritoneal tissue samples (collected during surgery) to evaluate tissue macrophage populations. * Provide cerebrospinal fluid (CSF) samples to assess biomarkers of blood-brain barrier permeability.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 18-30 years or over 60 years old

Scheduled for abdominal surgery

General anesthesia planned with or without spinal anesthesia

Able and willing to provide written informed consent.

Disqualifiers

Chemotherapy or systemic corticosteroid use within the past 2 weeks.

Pregnancy.

Active sepsis or systemic infection.

Emergency surgery.

Trial population

Adult patients from Hospital Clínico Universidad de Chile, in Santiago de Chile, that require elective abdominal surgery and are willing to participate in the study, meeting inclusion criteria and signing the informed consent.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

60 Participants
are grouped into 2 trial groups
Group A: Older adults
Group B: Young Adults

Trial outcomes

Primary outcomes

1

Frontal EEG alpha-band power

Relative EEG alpha power during surgery under general anesthesia guided by standard age-adjusted dosing

Time frame
Perioperative

Secondary outcomes

1

Time-to-loss of consciousness

During propofol slow induction, the time required for unresponsiveness to verbal stimuli

Time frame
Perioperative
2

Intraoperative anesthetic requirements

Total dose and infusion rate of propofol and/or sevoflurane adjusted using frontal EEG monitoring

Time frame
Perioperative
3

Time to emergence

Time in minutes to eye opening since end of anesthesia, with verbal stimuli.

Time frame
Perioperative
4

Cytokine circulating profile

Serum inflammatory cytokine profile

Time frame
Baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: